Upload
vukhanh
View
225
Download
0
Embed Size (px)
Citation preview
The Update GINA guideline The Update GINA guideline 2006 in Adult2006 in Adult
ผศ. นพ. วัชรา บุญสวัสดิ์ M.D., Ph.D.
ภาควิชาอายุรศาสตร คณะแพทยศาสตร
มหาวิทยาลัยขอนแกน
1975 1980 1985 1990 1995 2000
Changing concept in asthma treatment
Airway Hyperresponsiveness
Bronchospasm Inflammation
Remodelling
short-acting b2 -agonists Inh corticosteroid Combination
Six-part Asthma Management Program
Goals of Long-term Management
• Achieve and maintain control of symptoms
• Prevent asthma episodes or attacks
• Maintain pulmonary function as close to normal levels as possible
• Maintain normal activity levels, including exercise
• Avoid adverse effects from asthma medications
• Prevent development of irreversible airflow limitation
• Prevent asthma mortality
Six-part Asthma Management Program
Control of Asthma• Minimal (ideally no) chronic symptoms
• Minimal (infrequent) exacerbations
• No emergency visits
• Minimal (ideally no) need for “as needed” use of β2- agonist
• No limitations on activities, including exercise
• PEF circadian variation of less than 20 percent
• (Near) normal PEF
• Minimal (or no) adverse effects from medicine
Six-Part Asthma Management Program
1. Educate Patients
2. Assess and Monitor Severity
3. Avoid Exposure to Risk Factors
4. Establish Medication Plans for Chronic Management
5. Establish Plans for Managing Exacerbations
6. Provide Regular Follow-up Care
1995
Pharmacological therapy
ControllersInhaled corticosteroids
Inhaled long-acting β2-agonistsOral anti-leukotrienes Oral theophyllines
RelieversInhaled fast-acting β2-agonists
Classification of asthma severity:
GINA 1995
Day symptoms
Night symptoms
PEFR
PF variability
Intermittent
<1/wk
<2/mo
>80%
<20%
>1/wk
>2/mo
>80%
20-30%
daily
>1/wk
60-80%
>30%
daily
frequent
<60%
>30%
Mild
persistent
Moderate
persistent
Severe
Persistent1
23
4
High dose ICS+other controller
B2
agonist prnLevel 1
ICS
high dose ICS
Level 2
Level 3
Level 4
GINAGINA19951995
High dose ICS+other controller
B2
agonist prnLevel 1
ICS
high dose ICS
ICS+LABA+other controller
Level 2
Level 3
Level 4
ICS+LABA
GINAGINA19951995GINAGINA 20022002
Classification of asthma severity:
GINA 1995
Day symptoms
Night symptoms
PEFR
PF variability
Intermittent
<1/wk
<2/mo
>80%
<20%
>1/wk
>2/mo
>80%
20-30%
daily
>1/wk
60-80%
>30%
daily
frequent
<60%
>30%
Mild
persistent
Moderate
persistent
Severe
Persistent
TOO COMPLICATE
GGaining aining OOptimal ptimal AAsthma sthma controcontroLL (GOAL) study(GOAL) study
Bateman E. Am.
J.
Respir.
Crit.
Care Med.2004:836-844
Common views of control?Common views of control?Some?
A puff a day?
>80% on most days?
Occasional?
Rarely?
Rarely?
Symptoms
Salbutamol use
PEF am
Night-time awakenings
Exacerbations
Emergency visitsTreatment related adverse events
enforcing change in therapy None?
Some?
A puff a day?
>80% on most days?
Occasional?
Rarely?
Rarely?
Symptoms
Salbutamol use
PEF am
Night-time awakenings
Exacerbations
Emergency visitsTreatment related adverse events
enforcing change in therapy None?
GOAL Study
TTOTALOTAL CCONTROLONTROL definitiondefinition
Symptoms
Salbutamol use
>80% PEF am
Night-time awakenings
Exacerbations
Emergency visits
Treatment related adverse events enforcing change in therapy
No
No
Every day
No
No
No
No
TOTAL
CONTROL
is ALL of these sustained for at least 7 of 8 weeks
Strata 1 & 2
GOAL: a unique and innovative studyGOAL: a unique and innovative studyOral
prednisolone +SFC 50/500
Stratum 3
Step 3
SFC 50/500 or FP 500
VisitWeek
SFC, salmeterol/fluticasone propionate combination; FP, fluticasone propionate GSK data on file, 2003
1 2 3 4 5 6 7 8 9- 4 0 4 12 24 36 52 56
Phase IPhase II
8-week control assessment4-week control assessment
SFC 50/500 or FP 500
Step 2SFC 50/250 or FP 250
Step 1
Step 2
SFC 50/250 or FP 250
Step 1
SFC 50/100or FP 100
Seretide Phase 2Seretide Phase 1
FP Phase 2FP Phase 1
Steroid naïve Low doseICS
Moderate doseICS
Patients can achieve total control Patients can achieve total control regardless of asthma severityregardless of asthma severity
40%50%
28%
44%
16%
29%
0
20
40
60
80
100
% p
atie
nts
achi
evin
g to
tal c
ontro
lled
asth
ma
Approximately 50% patients achieved Total Control
More patients achieved well controlled More patients achieved well controlled asthma with Seretide versus FPasthma with Seretide versus FP
Steroid naïve Low doseICS
Moderate doseICS
70%60%
75%
47%
62%
78%
0
20
40
60
80
100
% p
atie
nts
achi
evin
g w
ell-c
ontro
lled
asth
ma
Seretide Phase 2Seretide Phase 1
FP Phase 2FP Phase 1
The recommendations for asthma management are laid out in five interrelated components of therapy:
1. Develop Patient/Doctor Partnership2. Identify and Reduce Exposure to Risk Factors3. Assess, Treat, and Monitor Asthma4. Manage Asthma Exacerbations5. Special Considerations
Levels of Asthma ControlCharacteristic Controlled
(All of the following)Partly Controlled(Any measure present in any week)
Uncontrolled
Daytime symptoms None (twice or less/week)
More than twice/week Three or more featuresof partly controlledasthma present
Limitations of activities None Any
Nocturnal symptoms/awakening
None Any
Need for reliever/rescue treatment
None (twice or less/week)
More than twice/week
Lung function (PEF or FEV1 )‡
Normal < 80% predicted or personal best (if known)
Exacerbations None One or more/year* One in any week†
* Any exacerbation should prompt review of maintenance treatment to ensure that it is adequate.†
By definition, an exacerbation in any week makes that an uncontrolled asthma week.‡ Lung function is not a reliable test for children 5 years and younger.
Pharmacological therapy
ControllersInhaled corticosteroids
Inhaled long-acting β2-agonistsOral anti-leukotrienes Oral theophyllines
RelieversInhaled fast-acting β2-agonists
High dose ICS+other controller
B2
agonist prnLevel 1
ICS
high dose ICS
ICS+LABA+other controller
Level 2
Level 3
Level 4
ICS+LABA
GINAGINA19951995GINAGINA 20022002
Simplified asthma treatment
Assess Control
ICS 500ug/d
Asthma Patient
Treatment
ICS 500ug/d+Other controller
No day symptomsNo night symptomsNo rescue medicationNo ER visitPEFR >80%
Total control